Literature DB >> 20882121

HIF-1α Promotes A Hypoxia-Independent Cell Migration.

Liyuan Li1, Chikezie O Madu, Andrew Lu, Yi Lu.   

Abstract

Hypoxia-inducible factor-1α (HIF-1α) is known as a transactivator for VEGF gene promoter. It can be induced by hypoxia. However, no study has been done so far to dissect HIF-1α-mediated effects from hypoxia or VEGF-mediated effects. By using a HIF-1α knockout (HIF-1α KO) cell system in mouse embryonic fibroblast (MEF) cells, this study analyzes cell migration and HIF-1α, hypoxia and VEGF activation. A hypoxia-mediated HIF-1α induction and VEGF transactivation were observed: both HIF-1α WT lines had significantly increased VEGF transactivation, as an indicator for HIF-1α induction, in hypoxia compared to normoxia; in contrast, HIF-1α KO line had no increased VEGF transactivation under hypoxia. HIF-1α promotes cell migration: HIF-1α-KO cells had a significantly reduced migration compared to that of the HIF-1α WT cells under both normoxia and hypoxia. The significantly reduced cell migration in HIF-1α KO cells can be partially rescued by the restoration of WT HIF-1α expression mediated by adenoviral-mediated gene transfer. Interestingly, hypoxia has no effect on cell migration: the cells had a similar cell migration rate under hypoxic and normoxic conditions for both HIF-1α WT and HIF-1α KO lines, respectively. Collectively, these data suggest that HIF-1α plays a role in MEF cell migration that is independent from hypoxia-mediated effects.

Entities:  

Year:  2010        PMID: 20882121      PMCID: PMC2946250          DOI: 10.2174/1874196701003010008

Source DB:  PubMed          Journal:  Open Biol J


  34 in total

Review 1.  HIF-1 and human disease: one highly involved factor.

Authors:  G L Semenza
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

Review 2.  The molecular players of sperm-egg fusion in mammals.

Authors:  Eric Rubinstein; Ahmed Ziyyat; Jean-Philippe Wolf; François Le Naour; Claude Boucheix
Journal:  Semin Cell Dev Biol       Date:  2006-03-02       Impact factor: 7.727

3.  A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis.

Authors:  M Miyake; S I Hakomori
Journal:  Biochemistry       Date:  1991-04-02       Impact factor: 3.162

4.  Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.

Authors:  M Ono; K Handa; D A Withers; S Hakomori
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

5.  Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1?

Authors:  Kevin D Burroughs; Jennifer Oh; J Carl Barrett; Richard P DiAugustine
Journal:  Mol Cancer Res       Date:  2003-02       Impact factor: 5.852

Review 6.  The role of autocrine motility factor in tumor and tumor microenvironment.

Authors:  Tatsuyoshi Funasaka; Avraham Raz
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

Authors:  O Iliopoulos; A P Levy; C Jiang; W G Kaelin; M A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma.

Authors:  Rob A Cairns; Richard P Hill
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

10.  Molecular signature associated with bone marrow micrometastasis in human breast cancer.

Authors:  Ute Woelfle; Jacqueline Cloos; Guido Sauter; Lutz Riethdorf; Fritz Jänicke; Paul van Diest; Ruud Brakenhoff; Klaus Pantel
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  10 in total

1.  Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia.

Authors:  Bingke Lv; Feng Li; Jie Fang; Limin Xu; Chengmei Sun; Jianbang Han; Tian Hua; Zhongfei Zhang; Zhiming Feng; Xiaodan Jiang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 2.  Action Sites and Clinical Application of HIF-1α Inhibitors.

Authors:  Renfeng Xu; Fan Wang; Hongqin Yang; Zhengchao Wang
Journal:  Molecules       Date:  2022-05-26       Impact factor: 4.927

3.  Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Yanqiong Liu; Jingzhe Sui; Limin Zhai; Shi Yang; Li Huang; Liying Huang; Cuiju Mo; Junrong Wu; Shan Li; Xue Qin
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

4.  Wound Healing Potential of Low Temperature Plasma in Human Primary Epidermal Keratinocytes.

Authors:  Hui Song Cui; Yoon Soo Cho; So Young Joo; Chin Hee Mun; Cheong Hoon Seo; June-Bum Kim
Journal:  Tissue Eng Regen Med       Date:  2019-09-04       Impact factor: 4.169

5.  Effects of Subnormothermic Regulated Hepatic Reperfusion on Mitochondrial and Transcriptomic Profiles in a Porcine Model.

Authors:  Joohyun Kim; Michael A Zimmerman; Woo Young Shin; Brent T Boettcher; Ju-Seog Lee; Jong-In Park; Muhammed Ali; Meiying Yang; Jyotsna Mishra; Catherine E Hagen; Joseph E McGraw; Angela Mathison; Harvey J Woehlck; Gwen Lomberk; Amadou K S Camara; Raul A Urrutia; David F Stowe; Johnny C Hong
Journal:  Ann Surg       Date:  2021-08-13       Impact factor: 12.969

6.  Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.

Authors:  Abderrahim El Guerrab; Rabah Zegrour; Carine-Christiane Nemlin; Flavie Vigier; Anne Cayre; Frederique Penault-Llorca; Fabrice Rossignol; Yves-Jean Bignon
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

7.  Physical confinement during cancer cell migration triggers therapeutic resistance and cancer stem cell-like behavior.

Authors:  Qionghua Shen; Tamara Hill; Xue Cai; Loan Bui; Rami Barakat; Emily Hills; Turki Almugaiteeb; Anish Babu; Patrick H Mckernan; Michelle Zalles; James D Battiste; Young-Tae Kim
Journal:  Cancer Lett       Date:  2021-02-25       Impact factor: 9.756

Review 8.  Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend.

Authors:  Mehdi Karimi-Shahri; Hossein Javid; Alireza Sharbaf Mashhad; Shaghayegh Yazdani; Seyed Isaac Hashemy
Journal:  Iran J Basic Med Sci       Date:  2021-10       Impact factor: 2.699

9.  P21-activated kinase regulates oxygen-dependent migration of vascular endothelial cells in monolayers.

Authors:  Satomi Hirose; Yugo Tabata; Kazuki Sone; Naoyuki Takahashi; Daisuke Yoshino; Kenichi Funamoto
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

10.  Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis.

Authors:  Anton Lennikov; Pierfrancesco Mirabelli; Anthony Mukwaya; Mira Schaupper; Muthukumar Thangavelu; Mieszko Lachota; Zaheer Ali; Lasse Jensen; Neil Lagali
Journal:  Angiogenesis       Date:  2018-01-13       Impact factor: 9.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.